Association of variants in the CP, ATOX1 and COMMD1 genes with Wilson disease symptoms in Latvia

1Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Prim. 2018; 4(1): 21. Członkowska A Litwin T Dusek P Ferenci P Lutsenko S Medici V et al Wilson disease Nat Rev Dis Prim 2018 41 2110.1016/B978-0-444-63625-6.00010-028433096Search in Google Scholar

2Ala A, Schilsky M. Genetic modifiers of liver injury in hereditary liver disease. Semin Liver Dis. 2011; 31(2): 208-214. Ala A Schilsky M Genetic modifiers of liver injury in hereditary liver disease Semin Liver Dis 2011 312 208 21410.1055/s-0031-127664821538285Search in Google Scholar

3Medici V, Weiss K-H. Genetic and environmental modifiers of Wilson disease. In: Członkowska A, Schilsky ML, Editors. Handbook of Clinical Neurology. Amsterdam, The Netherlands: Elsevier. 2017; 142: 35-41. Medici V Weiss K-H Genetic and environmental modifiers of Wilson disease Członkowska A Schilsky ML Editors Handbook of Clinical Neurology Amsterdam, The Netherlands Elsevier 2017 142 35 41Search in Google Scholar

4Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, et al. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype. Liver Int. 2019; 39(1): 177-186. Kluska A Kulecka M Litwin T Dziezyc K Balabas A Piatkowska M et al Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype Liver Int 2019 391 177 18610.1111/liv.1396730230192Search in Google Scholar

5Simon I, Schaefer M, Reichert J, Stremmel W. Analysis of the human Atox 1 homologue in Wilson patients. World J Gastroenterol. 2008; 14(15): 2383-2387. Simon I Schaefer M Reichert J Stremmel W Analysis of the human Atox 1 homologue in Wilson patients World J Gastroenterol 2008 1415 2383 238710.3748/wjg.14.2383270509418416466Search in Google Scholar

6Gupta A, Chattopadhyay I, Mukherjee S, Sengupta M, Das SK, Ray K. A novel COMMD1 mutation Thr174 Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient. Behav Brain Funct. 2010; 6: 33. Gupta A Chattopadhyay I Mukherjee S Sengupta M Das SK Ray K A novel COMMD1 mutation Thr174 Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient Behav Brain Funct 2010 6 3310.1186/1744-9081-6-33289633820550661Search in Google Scholar

7Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien J-P, David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci. 2002; 22(15): 6578-6586. Patel BN Dunn RJ Jeong SY Zhu Q Julien J-P David S Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury J Neurosci 2002 2215 6578 658610.1523/JNEUROSCI.22-15-06578.2002Search in Google Scholar

8Zhao N, Xiao J, Zheng Z, Fei G, Zhang F, Jin L, et al. Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson’s disease. Neurosci Bull. 2015; 31(2); 245-256. Zhao N Xiao J Zheng Z Fei G Zhang F Jin L et al Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson’s disease Neurosci Bull 2015 312 245 25610.1007/s12264-014-1512-6556370425758665Search in Google Scholar

9Adamsson Eryd S, Sjögren M, Smith JG, Nilsson PM, Melander O, Hedblad B, et al. Ceruloplasmin and atrial fibrillation: Evidence of causality from a population-based Mendelian randomization study. J Intern Med. 2014; 275(2): 164-171. Adamsson ErydS Sjögren M Smith JG Nilsson PM Melander O Hedblad B et al Ceruloplasmin and atrial fibrillation: Evidence of causality from a population-based Mendelian randomization study J Intern Med 2014 2752 164 17110.1111/joim.1214424118451Search in Google Scholar

10Arenas de Larriva AP, Norby FL, Chen LY, Soliman EZ, Hoogeveen RC, Arking DE, et al. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study. Int J Cardiol. 2017; 241: 223-228. Arenas de LarrivaAP Norby FL Chen LY Soliman EZ Hoogeveen RC Arking DE et al Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study Int J Cardiol 2017 241 223 22810.1016/j.ijcard.2017.04.005551566928427851Search in Google Scholar

11Ferenci P, Czlonkowska A, Stremmel W, Houwen R, Rosenberg W, Schilsky M, et al.; EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012; 56(3): 671-685. 2012. Ferenci P Czlonkowska A Stremmel W Houwen R Rosenberg W Schilsky M et al.; EASL Clinical Practice Guidelines: Wilson’s disease J Hepatol 2012 563 671 685 201210.1016/j.jhep.2011.11.00722340672Search in Google Scholar

12Gromadzka G, Schmidt HHJ, Genschel J, Bochow B, Rodo M, Tamacka B, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin Genet. 2005; 68(6): 524-532. Gromadzka G Schmidt HHJ Genschel J Bochow B Rodo M Tamacka B et al Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease Clin Genet 2005 686 524 53210.1111/j.1399-0004.2005.00528.x16283883Search in Google Scholar

13Poláková H, Katrincsáková B, Minárik G, Ferakova, E, Ficek A, Baldovic M, et al. Detection of His-1069Gln mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test. Gen Physiol Biophys. 2007; 26(2): 91-96. Poláková H Katrincsáková B Minárik G Ferakova E Ficek A Baldovic M et al Detection of His-1069Gln mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test Gen Physiol Biophys 2007 262 91 96Search in Google Scholar

14Krumina A, Keiss J, Sondore V, Chernushenko A, Cernevska G, Zarina A, et al. From clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia. Genetika. 2008; 44(10): 1379-1384. Krumina A Keiss J Sondore V Chernushenko A Cernevska G Zarina A et al From clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia Genetika 2008 4410 1379 138410.1134/S1022795408100086Search in Google Scholar

15Zarina A, Tolmane I, Kreile M, Chernushenko A, Cernevska G, Pukite I, et al. Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease. Mol Genet Genomic Med. 2017; 5(4): 405-409. Zarina A Tolmane I Kreile M Chernushenko A Cernevska G Pukite I et al Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease Mol Genet Genomic Med 2017 54 405 40910.1002/mgg3.297551179728717664Search in Google Scholar

16gnomAD. [Online]. Available: https://gnomad.broadinstitute.org/. [Accessed: April 15 2019]. gnomAD [Online]. Available https://gnomad.broadinstitute.org/ Accessed: April 15 2019Search in Google Scholar

17Chr13: 52.51M-52.51M, 1000 Genomes Browser. [Online]. Available: https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?gts=rs1057516740 [Accessed: October 16 2018]. Chr13: 52.51M-52.51M, 1000 Genomes Browser [Online]. Available https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?gts=rs1057516740 Accessed: October 16 2018Search in Google Scholar

18Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424. Richards S Aziz N Bale S Bick D Das S Gastier-Foster J et al Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 2015 175 405 42410.1038/gim.2015.30454475325741868Search in Google Scholar

19Human Splicing Finder, Version 3.1. [Online]. Available: http://www.umd.be/HSF3/. [Accessed: October 18 2018]. Human Splicing Finder, Version 3.1 [Online]. Available http://www.umd.be/HSF3/ Accessed: October 18 2018Search in Google Scholar

20Hedera P. Update on the clinical management of Wilson’s disease. Appl Clin Genet. 2017; 10: 9-19. Hedera P Update on the clinical management of Wilson’s disease Appl Clin Genet 2017 10 9 1910.2147/TACG.S79121524591628144156Search in Google Scholar

21Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: An update. Hepatology. 2008; 47(6): 2089-2111. Roberts EA Schilsky ML Diagnosis and treatment of Wilson disease: An update Hepatology 2008 476 2089 211110.1002/hep.2226118506894Search in Google Scholar

22Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002; 22(1): 439-458. Hellman NE Gitlin JD Ceruloplasmin metabolism and function Annu Rev Nutr 2002 221 439 45810.1146/annurev.nutr.22.012502.11445712055353Search in Google Scholar

23van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet. 2002; 11(2): 165-173. van De SluisB Rothuizen J Pearson PL van OostBA Wijmenga C Identification of a new copper metabolism gene by positional cloning in a purebred dog population Hum Mol Genet 2002 112 165 17310.1093/hmg/11.2.16511809725Search in Google Scholar

24Stuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients. J Mol Med. 2004; 82(9): 629-634. Stuehler B Reichert J Stremmel W Schaefer M Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients J Mol Med 2004 829 629 63410.1007/s00109-004-0557-915205742Search in Google Scholar

25Lovicu M, Dessi V, Lepori MB, Zappu A, Zancan L, Giacchino R, et al.. The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol. 2006; 41(6): 582-587. Lovicu M Dessi V Lepori MB Zappu A Zancan L Giacchino R et al The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease J Gastroenterol 2006 416 582 58710.1007/s00535-006-1807-016868807Search in Google Scholar

26Weiss KH, Merle U, Schaefer M, Ferenci P, Fullekrug J, Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol. 2006; 12(14): 2239-2242. Weiss KH Merle U Schaefer M Ferenci P Fullekrug J Stremmel W Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels World J Gastroenterol 2006 1214 2239 224210.3748/wjg.v12.i14.2239408765316610028Search in Google Scholar